Home / Ceftolozane and Beta-Lactamase Inhibitor / Sweden
SE ATC J01DI54 · updated 2 Nov 2026
Ceftolozane and Beta-Lactamase Inhibitor shortage in Sweden
Is there a Ceftolozane and Beta-Lactamase Inhibitor shortage in Sweden?
Yes. As of 2 Nov 2026, 1 Ceftolozane and Beta-Lactamase Inhibitor product is reported short in Sweden, the first since 29 Oct 2026. The company estimate for the return is 16 Nov 2026. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in Sweden
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| SE | Zerbaxa 1 g/0,5 g Injektionsflaska, 10 st | Merck Sharp & Dohme BV | 29 Oct 2026 | 16 Nov 2026 | Not stated |
Source
Läkemedelsverket (Swedish Medical Products Agency). Official list. Ongoing and announced shortages (restanmälningar) reported by companies; one row per pack.